Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Feldstein: Weight change in diabetes and glycemic and blood pressure control. (0.13 sec) 

Weight change in diabetes and glycemic and blood pressure control

- diabetesjournals.org
AC Feldstein, GA Nichols, DH Smith, VJ … - Diabetes Care, 2008 - Am Diabetes Assoc
RESULTS—The weight-trajectory groups were defined as higher stable weight (n =
418; 16.2%), lower stable weight (n = 1,542; 59.9%), weight gain (n = 300;
11.7%), and weight loss (n = 314; 12.2%). The latter had a mean weight loss ...
Cited by 4 - Related articles - All 6 versions

Insulin resistance: the role of intramuscular triglyceride and the importance of physical …


RJ Timmermans, WH Saris, LJ van Loon - Nederlands tijdschrift voor geneeskunde, 2006 - ncbi.nlm.nih.gov
In the Netherlands, the prevalence of diabetes is expected to rise from 480,000
to more than 650,000 patients by the year 2020. Numerous studies have reported a
strong correlation between elevated plasma-free fatty-acid levels, the ...
Cited by 1 - Related articles

[PDF] Ketogenic diets for weight loss: A review of their principles, safety and efficacy


P Sumithran, J Proietto - Obesity Research & Clinical Practice, 2008 - sochob.cl
Page 1. Obesity Research & Clinical Practice (2008) 2, 1—13 REVIEW Ketogenic diets
for weight loss: A review of their principles, safety and efficacy ...
Cited by 1 - Related articles - View as HTML - All 2 versions

Effect of weight loss and ketosis on postprandial cholecystokinin and free fatty acid …

- ajcn.org
S Chearskul, E Delbridge, A Shulkes, J … - American Journal of Clinical Nutrition, 2008 - Am Soc Nutrition
Design: The study had a within-subject repeated-measure design [12 healthy,
obese men, 33-64 y, body mass index (in kg/m 2 ) 30–46] and was a clinical
intervention investigation of circulating metabolites and hunger-satiety ...
Cited by 1 - Related articles - BL Direct - All 5 versions

Association of Endogenous Sex Hormones With Diabetes andImpaired Fasting Glucose in …

- diabetesjournals.org
LA Colangelo, P Ouyang, K Liu, P Kopp, SH … - Diabetes Care, 2009 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS A total of 3,156 African American, Non-Hispanic
white, Hispanic, and Chinese-American men aged 45–84 years who participated in
the baseline visit of the Multi-Ethnic Study of Atherosclerosis (MESA) were ...
Cited by 1 - Related articles - All 3 versions

Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: …


V Delghingaro-Augusto, CJ Nolan, D Gupta, TL … - Diabetologia, 2009 - Springer
Page 1. ARTICLE Islet beta cell failure in the 60% pancreatectomised obese
hyperlipidaemic Zucker fatty rat: severe dysfunction with ...
Cited by 1 - Related articles - All 2 versions

Weight Loss in type 2 Diabetics Improves Vascular and Cardiac Contractile Function


C Piantadosi, R Duncan, A Nelson, G Wittert … - Heart, Lung and Circulation, 2008 - Elsevier
Methods: Twenty-one overweight Type 2 diabetic men (age: 49 ± 14 years),
underwent cardiac magnetic resonance (CMR) (1.5 T Siemens Sonata) and
echocardiography (GE Vivid-7) before and after an 8-week 800 cal/day weight ...
Cited by 1 - Related articles

Relation of adipose tissue to metabolic flexibility


LM Sparks, B Ukropcova, J Smith, M Pasarica, … - Diabetes research and clinical practice, 2009 - pubmedcentral.nih.gov
Metabolic flexibility is the capacity for skeletal muscle to shift reliance
between lipids and glucose during fasting or in response to insulin. We
hypothesized that body fat, adipose tissue characteristics, eg larger ...
Cited by 2 - Related articles - All 12 versions

Diabetes of the Liver: The Link Between Nonalcoholic Fatty Liver Disease and HFCS-55


KS Collison, SM Saleh, RH Bakheet, RK Al- … - Obesity, 2009 - nature.com
Nonalcoholic fatty liver disease (NAFLD) is associated with obesity and insulin
resistance. It is also a predisposing factor for type 2 diabetes. Dietary
factors are believed to contribute to all three diseases. NAFLD is ...
Cited by 1 - Related articles - All 3 versions

Fibroblast growth factor 21: an overview from a clinical perspective


M Rydén - Cellular and Molecular Life Sciences, 2009 - Springer
Abstract Fibroblast growth factor 21 (FGF21) has been proposed as a novel
putative therapeutic agent in type 2 diabetes. A large amount of data,
predominantly obtained from murine models but also from non-human primates, ...
Cited by 1 - Related articles - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google